Towards omics-based risk assessment in NAFLD

Nat Metab. 2023 Apr;5(4):534-535. doi: 10.1038/s42255-023-00772-4.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Genomics
  • Humans
  • Non-alcoholic Fatty Liver Disease* / genetics
  • Proteomics
  • Risk Assessment